Cargando…

Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation

BACKGROUND: The first UK interim clinical commissioning policy for the treatment of non-hospitalised patients with COVID-19 was published in December 2021. A service was established in Northern Ireland, with implementation and developments overseen by a multi-agency group. We investigated the reach,...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, L, McGuinness, S, Bradley, D T, Corrigan, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596445/
http://dx.doi.org/10.1093/eurpub/ckad160.1371
_version_ 1785125106175967232
author Patterson, L
McGuinness, S
Bradley, D T
Corrigan, D
author_facet Patterson, L
McGuinness, S
Bradley, D T
Corrigan, D
author_sort Patterson, L
collection PubMed
description BACKGROUND: The first UK interim clinical commissioning policy for the treatment of non-hospitalised patients with COVID-19 was published in December 2021. A service was established in Northern Ireland, with implementation and developments overseen by a multi-agency group. We investigated the reach, uptake and equity of the programme to understand performance and offer recommendations for improvement. DESCRIPTION OF THE PROBLEM: Data were extracted for 16 December 2021 to 16 December 2022. The objectives were to: 1) describe referrals over time using weekly aggregate returns sourced from the commissioning agency for all of NI and; 2) for a subset of providers, to describe treatment acceptance and those treated by age group, sex, deprivation quintile and all-cause mortality using anonymised, linked administrative data. Treatment acceptance was analysed using logistic regression. RESULTS: Overall, 16,454 patients were referred of whom 9,536 (58%) were eligible for treatment. Of these, 5,849 (61.3%) accepted, 1,215 (12.7%) declined, 1,140 (12%) were already an inpatient and the remainder unknown (1,332; 14%). Using the subset, treatment acceptance was associated with increasing age (likelihood ratio test (LRT) P = 0.02) but not deprivation (LRT P = 0.83). Of those treated (3,645 people) the majority were aged 18-64 years (68%) and were female (59%). Just 8% lived in the ‘most deprived’ quintile, compared to 20% in all others. The 28-day all-cause mortality for those recommended treatment was <1%. LESSONS: This was a rapidly established service which has treated 5,849 people. Acceptance of treatment increased with age but was not affected by deprivation. However, a higher percentage of those treated were from least deprived areas. Recommendations include monitoring equitability of access and a greater focus on those eligible for treatment but who decline, both highlighting the importance of engaging and empowering service users to make an informed choice around COVID-19 treatment. KEY MESSAGES: • Almost 6,000 people in the community have received a COVID-19 treatment since the inception of the service in Northern Ireland. • Equitability of access should continue to be monitored.
format Online
Article
Text
id pubmed-10596445
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105964452023-10-25 Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation Patterson, L McGuinness, S Bradley, D T Corrigan, D Eur J Public Health Poster Displays BACKGROUND: The first UK interim clinical commissioning policy for the treatment of non-hospitalised patients with COVID-19 was published in December 2021. A service was established in Northern Ireland, with implementation and developments overseen by a multi-agency group. We investigated the reach, uptake and equity of the programme to understand performance and offer recommendations for improvement. DESCRIPTION OF THE PROBLEM: Data were extracted for 16 December 2021 to 16 December 2022. The objectives were to: 1) describe referrals over time using weekly aggregate returns sourced from the commissioning agency for all of NI and; 2) for a subset of providers, to describe treatment acceptance and those treated by age group, sex, deprivation quintile and all-cause mortality using anonymised, linked administrative data. Treatment acceptance was analysed using logistic regression. RESULTS: Overall, 16,454 patients were referred of whom 9,536 (58%) were eligible for treatment. Of these, 5,849 (61.3%) accepted, 1,215 (12.7%) declined, 1,140 (12%) were already an inpatient and the remainder unknown (1,332; 14%). Using the subset, treatment acceptance was associated with increasing age (likelihood ratio test (LRT) P = 0.02) but not deprivation (LRT P = 0.83). Of those treated (3,645 people) the majority were aged 18-64 years (68%) and were female (59%). Just 8% lived in the ‘most deprived’ quintile, compared to 20% in all others. The 28-day all-cause mortality for those recommended treatment was <1%. LESSONS: This was a rapidly established service which has treated 5,849 people. Acceptance of treatment increased with age but was not affected by deprivation. However, a higher percentage of those treated were from least deprived areas. Recommendations include monitoring equitability of access and a greater focus on those eligible for treatment but who decline, both highlighting the importance of engaging and empowering service users to make an informed choice around COVID-19 treatment. KEY MESSAGES: • Almost 6,000 people in the community have received a COVID-19 treatment since the inception of the service in Northern Ireland. • Equitability of access should continue to be monitored. Oxford University Press 2023-10-24 /pmc/articles/PMC10596445/ http://dx.doi.org/10.1093/eurpub/ckad160.1371 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Displays
Patterson, L
McGuinness, S
Bradley, D T
Corrigan, D
Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title_full Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title_fullStr Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title_full_unstemmed Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title_short Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
title_sort provision of covid-19 treatments to non-hospitalised patients in northern ireland: an evaluation
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596445/
http://dx.doi.org/10.1093/eurpub/ckad160.1371
work_keys_str_mv AT pattersonl provisionofcovid19treatmentstononhospitalisedpatientsinnorthernirelandanevaluation
AT mcguinnesss provisionofcovid19treatmentstononhospitalisedpatientsinnorthernirelandanevaluation
AT bradleydt provisionofcovid19treatmentstononhospitalisedpatientsinnorthernirelandanevaluation
AT corrigand provisionofcovid19treatmentstononhospitalisedpatientsinnorthernirelandanevaluation